Therefore, it will not be favorable to use P-gp-inhibitors in this scenario, as this might reduce the cytotoxic potential of these tumor infiltrating anti-cancer Th1 and Th17 CD4+T cell phenotypes (118). Here, PGP is linked to cancer.